<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02797743</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-111-HEALTHY</org_study_id>
    <nct_id>NCT02797743</nct_id>
  </id_info>
  <brief_title>Whole Blood Specimen Collection From Healthy Subjects</brief_title>
  <official_title>Whole Blood Specimen Collection From Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Progenity, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Progenity, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will obtain whole blood specimens from healthy subjects to be used for research&#xD;
      and development and clinical validation of genetic assays.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Progenity is developing diagnostic products to improve the healthcare of men, women, and&#xD;
      children. The commercial objective is to make safe, noninvasive genetic testing available to&#xD;
      the public, independent of age and other factors that may contribute to pregnancy or other&#xD;
      clinical complications.&#xD;
&#xD;
      Sample specimens will not be used to develop genetic lines and/or DNA banks for cloning. Any&#xD;
      samples or remnant specimens remaining may be stored indefinitely for future research&#xD;
      programs.&#xD;
&#xD;
      Eligible subjects (or parent/guardian) will provide written informed consent after which&#xD;
      basic demographic and clinical data will be obtained and a whole blood sample will be&#xD;
      collected. A subject's participation may end immediately after their blood draw. The amount&#xD;
      of whole blood drawn at any visit will be based upon age of the subject and test to be&#xD;
      performed.&#xD;
&#xD;
      In the event a Subject is pregnant, information regarding the gender of the fetus established&#xD;
      by either ultrasound, non-invasive prenatal testing (NIPT) results, or at delivery will be&#xD;
      collected. Clinical data regarding any karyotyping procedure that may occur on the fetus will&#xD;
      be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Whole blood collection</measure>
    <time_frame>about 3 years</time_frame>
    <description>Whole blood collection from 750 healthy subjects total</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Whole blood from all ages and gender</arm_group_label>
    <description>- Ages from 0 to Adults (18 yrs of age or older)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole blood</intervention_name>
    <description>Adults â‰¥18 yrs of age: up to 50 mL (5 tubes)&#xD;
Adolescents 12-17 yrs of age: up to 30 mL (3 tubes)&#xD;
Children 0-11 yrs of age: single tube (1 tube, 10 mL)</description>
    <arm_group_label>Whole blood from all ages and gender</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Men, pregnant women or children, no age restrictions.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject (or guardian)is willing to provide written informed consent to have up to 50&#xD;
             mL of whole blood collected at a single clinic visit (maximum blood volume will depend&#xD;
             on age of subject)&#xD;
&#xD;
          -  Subject is considered healthy (and if pregnant, their pregnancy is progressing&#xD;
             normally)&#xD;
&#xD;
          -  If pregnant, Subject is carrying a singleton fetus of 10 to 26 weeks' gestational age&#xD;
             inclusive&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are not pregnant&#xD;
&#xD;
          -  If pregnant, pregnancy is non-viable&#xD;
&#xD;
          -  If pregnant, evidence of or suspected fetal anomaly based on ultrasound finding,&#xD;
             abnormal 1st trimester screening or abnormal NIPT&#xD;
&#xD;
          -  Immediate family history of a previous fetal aneuploidy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Stiegler, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Head of Clinical Affairs</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heinen Obstetrics &amp; Gynecology</name>
      <address>
        <city>Eunice</city>
        <state>Louisiana</state>
        <zip>70535</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virtua Medical Group</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Obgyn</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 25, 2016</study_first_submitted>
  <study_first_submitted_qc>June 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2016</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy Volunteers</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

